The ubiquitin proteasome system in glia and its role in neurodegenerative diseases

Frontiers in Molecular Neuroscience

Volumn 7, Issue AUG, 2014, Pages

  Jansen, Anne H P ^a   Reits, Eric A J ^a   Hol, Elly M ^b,c,d  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Astrocytes; Gliosis; Microglia; Neurodegenerative diseases; Oligodendrocytes; Ubiquitin proteasome system

Indexed keywords

EID: 84905721968     PISSN: 16625099     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnmol.2014.00073     Document Type: Review

References (161)

1. Abbott, N. J. (2002). Astrocyte-endothelial interactions and blood-brain barrier permeability. J. Anat. 200, 629-638. doi: 10.1046/j.1469-7580.2002.00064.x
2. Alexianu, M. E., Kozovska, M., and Appel, S. H. (2001). Immune reactivity in a mouse model of familial ALS correlates with disease progression. Neurology 57, 1282-1289. doi: 10.1212/WNL.57.7.1282
3. Ali, S.F., Binienda, Z.K., and Imam, S.Z. (2011). Molecular aspects of dopaminergic neurodegeneration: gene-environment interaction in Parkin dysfunction. Int. J. Environ. Res. PublicHealth 8, 4702-4713. doi: 10.3390/ijerph8124702
4. Alliot, F., Godin, I., and Pessac, B. (1999). Microglia derive from progenitors, originating from the yolk sac, and which proliferate in the brain. Dev. Brain Res. 117, 145-152. doi: 10.1016/S0165-3806(99)00113-3
5. Aloisi, F. (2001). Immune function of microglia. Glia 36, 165-179. doi: 10.1002/glia.1106
6. Amor, S., Peferoen, L. A., Vogel, D. Y., Breur, M., Van Der Valk, P., Baker, D., et al. (2013).Inflammation in neurodegenerative diseases - an update. Immunology 142, 151-166. doi: 10.1111/imm.12233
7. Aquilano, K., Rotilio, G., and Ciriolo, M. R. (2003). Proteasome activation and nNOS down-regulation in neuroblastoma cells expressing a Cu, Zn superoxide dismutase mutant involved in familial ALS. J. Neurochem. 85, 1324-1335. doi: 10.1046/j.1471-4159.2003.01783.x
8. Arrasate, M., Mitra, S., Schweitzer, E. S., Segal, M. R., and Finkbeiner, S. (2004). Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature 431, 805-810. doi: 10.1038/nature02998
9. Basler, M., Kirk, C. J., and Groettrup, M. (2013). The immunoproteasome in antigen processing and other immunological functions. Curr. Opin. Immunol. 25, 74-80. doi: 10.1016/j.coi.2012.11.004
10. Baumann, N., and Pham-Dinh, D. (2001). Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol. Rev. 81, 871-927.
11. Baumeister, W., Walz, J., Zühl, F., and Seemüller, E. (1998). The protea-some: paradigm of a self-compartmentalizing protease. Cell 92, 367-380. doi: 10.1016/S0092-8674(00)80929-0
12. Bedford, L., Hay, D., Devoy, A., Paine, S., Powe, D. G., Seth, R., et al. (2008). Depletion of 26S proteasomes in mouse brain neurons causes neurodegeneration and Lewy-like inclusions resembling human pale bodies. J. Neurosci. 28, 8189-8198. doi: 10.1523/JNEUROSCI.2218-08.2008
13. Beers, D. R., Henkel, J. S., Xiao, Q., Zhao, W., Wang, J., Yen, A. A., et al. (2006). Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis. Proc. Nati. Acad. Sci. U.S.A. 103, 16021-16026. doi: 10.1073/pnas.0607423103
14. Bellavista, E., Santoro, A., Galimberti, D., Comi, C., Luciani, F., and Mishto, M. (2014).Current understanding on the role of standard and immunoproteasomes in inflammatory/immunological pathways of multiple sclerosis. AutoimmuneDis. 2014, 739-705. doi: 10.1155/2014/739705
15. Bendotti, C., Marino, M., Cheroni, C., Fontana, E., Crippa, V., Poletti, A., et al. (2012). Dysfunction of constitutive and inducible ubiquitin-proteasome system in amyotrophic lateral sclerosis: implication for protein aggregation and immune response. Prog. Neurobiol. 97, 101-126. doi: 10.1016/j.pneurobio.2011. 10.001
16. Bi, W., Jing, X., Zhu, L., Liang, Y., Liu, J., Yang, L., et al. (2012). Inhibition of 26S protease regulatory subunit 7 (MSS1) suppresses neuroinflammation. PLoS ONE 7:e36142. doi: 10.1371/journal.pone.0036142
17. Bozzali, M., Padovani, A., Caltagirone, C., and Borroni, B. (2011). Regional grey matter loss and brain disconnection across Alzheimer disease evolution. Curr. Med. Chem. 18, 2452-2458. doi: 10.2174/092986711795843263
18. Bradford, J., Shin, J., Roberts, M., Wang, C., Li, X., and Li, S. (2009). Expression of mutant huntingtin in mouse brain astrocytes causes age-dependent neurological symptoms. Proc. Natl. Acad. Sci. U.S.A. 106, 22480-22485. doi: 10.1073/pnas.0911503106
19. Bradl, M., and Lassmann, H. (2010). Oligodendrocytes: biology and pathology. Acta Neuropathol. 119, 37-53. doi: 10.1007/s00401-009-0601-5
20. Brenner, M., Johnson, A. B., Boespflug-Tanguy, O., Rodriguez, D., Goldman, J. E., and Messing, A. (2001). Mutations in Gfap, encoding glial fibrillary acidic protein, are associated with Alexander disease. Nat. Genet. 27, 117-120. doi: 10.1038/83679
21. Brettschneider, J., Del Tredici, K., Toledo, J. B., Robinson, J. L., Irwin, D. J., Grossman, M., et al. (2013). Stages of pTDP-43 pathology in amyotrophic lateral sclerosis. Ann. Neurol. 74,20-38. doi: 10.1002/ana.23937
22. Bruijn, L. I., Becher, M. W., Lee, M. K., Anderson, K. L., Jenkins, N. A., Copeland, N. G., et al. (1997). ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron 18, 327-338. doi: 10.1016/S0896-6273(00)80272-X
23. Casarejos, M. J., Solano, R. M., Rodriguez-Navarro, J. A., Gomez, A., Perucho, J., Castano, J. G., et al. (2009). Parkin deficiency increases the resistance of midbrain neurons and glia to mild proteasome inhibition: the role of autophagy and glutathione homeostasis. J. Neurochem. 110, 1523-1537. doi: 10.1111/j.1471-4159.2009.06248.x
24. Cheroni, C., Marino, M., Tortarolo, M., Veglianese, P., De Biasi, S., Fontana, E., et al. (2009). Functional alterations of the ubiquitin-proteasome system in motor neurons of a mouse model of familial amyotrophic lateral sclerosis. Hum. Mol. Genet. 18, 82-96. doi: 10.1093/hmg/ddn319
25. Cho, W., and Messing, A. (2009). Properties of astrocytes cultured from GFAP over-expressing and GFAP mutant mice. Exp. Cell Res. 315, 1260-1272. doi: 10.1016/j.yexcr.2008.12.012
26. Choi, K., Park, J., Lee, J., Han, E. C., and Choi, C. (2013). Mutant ubiq-uitin attenuates interleukin-1beta- and tumor necrosis factor-alpha-induced pro-inflammatory signaling in human astrocytic cells. PLoS ONE 8:e67891. doi: 10.1371/journal.pone.0067891
27. Chou, S. Y., Weng, J. Y., Lai, H. L., Liao, F., Sun, S. H., Tu, P. H., et al. (2008). Expanded-polyglutamine huntingtin protein suppresses the secretion and production of a chemokine (CCL5/RANTES) by astrocytes. J. Neurosci. 28, 3277-3290. doi: 10.1523/JNEUROSCI.0116-08.2008
28. Chu, C. T., Caruso, J. L., Cummings, T. J., Ervin, J., Rosenberg, C., and Hulette, C. M. (2000). Ubiquitin immunochemistry as a diagnostic aid for community pathologists evaluating patients who have dementia. Mod. Pathol. 13, 420-426. doi: 10.1038/modpathol.3880072
29. Chung, W. S., Clarke, L. E., Wang, G. X., Stafford, B. K., Sher, A., Chakraborty, C., et al. (2013). Astrocytes mediate synapse elimination through MEGF10 and MERTK pathways. Nature 504, 394-400. doi: 10.1038/nature12776
30. Clement, A. M., Nguyen, M. D., Roberts, E. A., Garcia, M. L., Boillee, S., Rule, M., et al. (2003). Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science 302, 113-117. doi: 10.1126/science. 1086071
31. Cumiskey, D., O'Connor, J. J., and Pickering, M. (2005). Actions of TNF-alpha on glutamatergic synaptic transmission in the central nervous system. Exp. Physiol. 90, 663-670. doi: 10.1113/expphysiol.2005.030734
32. Dalal, N. V., Pranski, E. L., Tansey, M. G., Lah, J. J., Levey, A. I., and Betarbet, R. S. (2012). RNF11 modulates microglia activation through NF-kB signalling cascade. Neurosci. Lett. 528, 174-179. doi: 10.1016/j.neulet.2012.08.060
33. Davies, S. W., Turmaine, M., Cozens, B. A., Difiglia, M., Sharp, A. H., Ross, C. A., et al. (1997). Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90, 537-548. doi: 10.1016/S0092-8674(00)80513-9
34. de Lau, L. M., and Breteler, M. M. (2006). Epidemiology of Parkinson's disease. LancetNeurol. 5, 525-535. doi: 10.1016/S1474-4422(06)70471-9
35. Diaz-Hernândez, M., Hernandez, F., Martin-Aparicio, E., Gomez-Ramos, P., Moran, M. A., Castano, J. G., et al. (2003). Neuronal induction of the immunoproteasome in Huntington's disease. J. Neurosci. 23, 11653-11661.
36. DiFiglia, M., Sapp, E., Chase, K. O., Davies, S. W., Bates, G. P., Vonsattel, J. P., et al. (1997). Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277, 1990-1993. doi: 10.1126/sci-ence.277.5334.1990
37. Ding, Q., Dimayuga, E., Markesbery, W. R., and Keller, J. N. (2004). Pro-teasome inhibition increases DNA and RNA oxidation in astrocyte and neuron cultures. J. Neurochem. 91, 1211-1218. doi: 10.1111/j.1471-4159.2004. 02802.x
38. Elkharaz, J., Ugun-Klusek, A., Constantin-Teodosiu, T., Lawler, K., Mayer, R. J., Billett, E., et al. (2013). Implications for oxidative stress and astrocytes following 26S proteasomal depletion in mouse forebrain neurones. Biochim. Biophys. Acta 1832, 1930-1938. doi: 10.1016/j.bbadis.2013.07.002
39. Evans, M. C., Couch, Y., Sibson, N., and Turner, M. R. (2013). Inflammation and neurovascular changes in amyotrophic lateral sclerosis. Mol. Cell. Neurosci. 53, 34-41. doi: 10.1016/j.mcn.2012.10.008
40. Faideau, M., Kim, J., Cormier, K., Gilmore, R., Welch, M., Auregan, G., et al. (2010). In vivo expression of polyglutamine-expanded huntingtin by mouse striatal astrocytes impairs glutamate transport: a correlation with Huntington's disease subjects. Hum. Mol. Genet. 19, 3053-3067. doi: 10.1093/hmg/ ddq212
41. Ferrer, I., Lopez-Gonzalez, I., Carmona, M., Arregui, L., Dalfo, E., Torrejon-Escribano, B., et al. (2014). Glial and neuronal tau pathology in tauopathies: characterization of disease-specific phenotypes and tau pathology progression. J. Neuropathol. Exp. Neurol. 73, 81-97. doi: 10.1097/NEN.0000000000000030
42. Forsberg, K., Andersen, P., Marklund, S. L., and Brannstrom, T. (2011). Glial nuclear aggregates of superoxide dismutase-1 are regularly present in patients with amyotrophic lateral sclerosis. Acta Neuropathol. 121, 623-634. doi: 10.1007/s00401-011-0805-3
43. Ginhoux, F., Greter, M., Leboeuf, M., Nandi, S., See, P., Gokhan, S., et al. (2010). Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 330, 841-845. doi: 10.1126/science.1194637
44. Glickman, M. H., and Ciechanover, A. (2002). The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol. Rev. 82,373-428. doi: 10.1152/physrev.00027.2001
45. Goldbaum, O., Riedel, M., Stahnke, T., and Richter-Landsberg, C. (2009). The small heat shock protein HSP25 protects astrocytes against stress induced by proteasomal inhibition. Glia 57, 1566-1577. doi: 10.1002/glia.20870
46. Goldbaum, O., Vollmer, G., and Richter-Landsberg, C. (2006). Proteasome inhibition by MG-132 induces apoptotic cell death and mitochondrial dysfunction in cultured rat brain oligodendrocytes but not in astrocytes. Glia 53, 891-901. doi: 10.1002/glia.20348
47. Gong, Y. H., Parsadanian, A. S., Andreeva, A., Snider, W. D., and Elliott, J. L. (2000). Restricted expression of G86R Cu/Zn superoxide dismutase in astrocytes results in astrocytosis but does not cause motoneuron degeneration. J. Neurosci. 20, 660-665.
48. Gray, F., Scaravilli, F., Everall, I., Chretien, F., An, S., Boche, D., et al. (1996). Neuropathology of early HIV-1 infection. Brain Pathol. 6, 1-15. doi: 10.1111/j.1750-3639.1996.tb00775.x
49. Gregori, L., Fuchs, C., Figueiredo-Pereira, M. E., Van Nostrand, W. E., and Goldgaber, D. (1995). Amyloid p-protein inhibits ubiquitin-dependent protein degradation in vitro. J. Biol. Chem. 270, 19702-19708. doi: 10.1074/jbc.270.34.19702
50. Griffin, W. S., Stanley, L. C., Ling, C., White, L., Macleod, V., Perrot, L. J., et al. (1989). Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 86, 7611-7615. doi: 10.1073/pnas.86.19.7611
51. Gu, X. L., Long, C. X., Sun, L., Xie, C., Lin, X., and Cai, H. (2010). Astrocytic expression of Parkinson's disease-related A53T alpha-synuclein causes neurodegeneration in mice. Mol. Brain 3, 12. doi: 10.1186/17566606-3-12
52. Halliday, G. M., and Stevens, C. H. (2011). Glia: initiators and progressors of pathology in Parkinson's disease. Mov. Disord. 26, 6-17. doi: 10.1002/mds.23455
53. Han, I., You, Y., Kordower, J. H., Brady, S. T., and Morfini, G. A. (2010). Differential vulnerability of neurons in Huntington's disease: the role of cell type-specific features. J. Neurochem. 113, 1073-1091. doi: 10.1111/j.1471-4159.2010. 06672.x
54. Hardy, J., Lewis, P., Revesz, T., Lees, A., and Paisan-Ruiz, C. (2009). The genetics of Parkinson'ssyndromes:acritical review. Curr. Opin. Genet. Dev. 19,254-265. doi: 10.1016/j.gde.2009.03.008
55. Hipp, M. S., Kalveram, B., Raasi, S., Groettrup, M., and Schmidtke, G. (2005). FAT10, a ubiquitin-independent signal for proteasomal degradation. Mol. Cell. Biol. 25, 3483-3491. doi: 10.1128/MCB.25.9.3483-3491.2005
56. Holmberg, C. I., Staniszewski, K. E., Mensah, K. N., Matouschek, A., and Morimoto, R. I. (2004). Inefficient degradation of truncated polyglutamine proteins by the proteasome. EMBO J. 23, 4307-4318. doi: 10.1038/sj.emboj. 7600426
57. Hunter, J. M., Lesort, M., and Johnson, G. V. W. (2007). Ubiquitin-proteasome system alterations in a striatal cell model of Huntington's disease. J. Neurosci. Res. 85, 1774-1788. doi: 10.1002/jnr.21287
58. Imai, Y., Soda, M., and Takahashi, R. (2000). Parkin suppresses unfolded protein stress-induced cell death through its E3 ubiquitin-protein lig-ase activity. J. Biol. Chem. 275, 435661-435664. doi: 10.1074/jbc. C000447200
59. Juenemann, K., Schipper-Krom, S., Wiemhoefer, A., Kloss, A., Sanz Sanz, A., and Reits, E.A. J. (2013). Expandedpolyglutamine-containingN-terminal huntingtin fragments are entirely degraded by mammalian proteasomes. J. Biol. Chem. 288, 27068-27084. doi: 10.1074/jbc.M113.486076
60. Kabashi, E., Agar, J. N., Hong, Y., Taylor, D. M., Minotti, S., Figlewicz, D. A., et al. (2008). Proteasomes remain intact, but show early focal alteration in their composition in a mouse model of amyotrophic lateral sclerosis. J. Neurochem. 105,2353-2366. doi: 10.1111/j.1471-4159.2008.05317.x
61. Kamphuis, W., Orre, M., Kooijman, L., Dahmen, M., and Hol, E. M. (2012). Differential cell proliferation in the cortex of the APPswePS1dE9 Alzheimer's disease mouse model. Glia 60, 615-629. doi: 10.1002/ glia.22295
62. Kawanokuchi, J., Mizuno, T., Takeuchi, H., Kato, H., Wang, J., Mitsuma, N., et al. (2006). Production of interferon-gamma by microglia. Mult. Scler. 12, 558-564. doi: 10.1177/1352458506070763
63. Keller, J. N., Hanni, K. B., and Markesbery, W. R. (2000). Impaired proteasome function in Alzheimer's Disease. J. Neurochem. 75, 436-439. doi: 10.1046/j.1471-4159.2000.0750436.x
64. Kettenmann, H., Kirchhoff, F., and Verkhratsky, A. (2013). Microglia: newroles for the synaptic stripper. Neuron 77, 10-18. doi: 10.1016/j.neuron.2012.12.023
65. Kettenmann, H., andVerkhratsky, A. (2008). Neuroglia: the 150 years after. Trends Neurosci. 31, 653-659. doi: 10.1016/j.tins.2008.09.003
66. Kraft, A. W., Hu, X., Yoon, H., Yan, P., Xiao, Q., Wang, Y., et al. (2013). Attenuating astrocyte activation accelerates plaque pathogenesis in APP/PS1 mice. FASEB J. 27, 187-198. doi: 10.1096/fj.12-208660
67. Kuzdas, D., Stemberger, S., Gaburro, S., Stefanova, N., Singewald, N., and Wenning, G. K. (2013). Oligodendroglial alpha-synucleinopathy and MSA-like cardiovascular autonomic failure: experimental evidence. Exp. Neurol. 247, 531-536. doi: 10.1016/j.expneurol.2013.02.002
68. Kwan, W., Trager, U., Davalos, D., Chou, A., Bouchard, J., Andre, R., et al. (2012). Mutant huntingtin impairs immune cell migration in Huntington disease. J. Clin. Invest. 122,4737-4747. doi: 10.1172/JCI64484
69. Kwon, S., Ahn, T., Yoon, M., and Jeon, B. S. (2008). Bv-2 stimulation by lactacystin results in a strong inflammatory reaction and apoptotic neuronal death in SH-SY5Y cells. Brain Res. 1205, 116-121. doi: 10.1016/j.brainres.2008. 02.030
70. Lam, Y. A., Pickart, C. M., Alban, A., Landon, M., Jamieson, C., Ramage, R., et al. (2000). Inhibition of the ubiquitin-proteasome system in Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 97, 9902-9906. doi: 10.1073/pnas.170173897
71. Lee, H., Suk, J., Patrick, C., Bae, E., Cho, J., Rho, S., et al. (2010). Direct transfer of a-synuclein from neuron to astroglia causes inflammatory responses in synucleinopathies. J. Biol. Chem. 285, 9262-9272. doi: 10.1074/jbc.M109. 081125
72. Leigh, P. N., Whitwell, H., Garofalo, O., Buller, J., Swash, M., Martin, J. E., et al. (1991). Ubiquitin-immunoreactive intraneuronal inclusions in amyotrophic lateral sclerosis. Morphology, distribution, and specificity. Brain J. Neurol. 114, 775-788. doi: 10.1093/brain/114.2.775
73. Li, S., Yu, Z., Li, C., Nguyen, H., Zhou, Y., Deng, C., et al., (2003). Lack of huntingtin-associated protein-1 causes neuronal death resembling hypothalamic degeneration in Huntington's disease. J. Neurosci. 23, 6956-6964.
74. Li, X., Wang, C., Huang, S., Xu, X., Li, X., Li, H., et al. (2010). Inhibiting the ubiquitin-proteasome system leads to preferential accumulation of toxic N-terminal mutant huntingtin fragments. Hum. Mol. Genet. 19, 2445-2455. doi: 10.1093/hmg/ddq127
75. Lilienbaum, A. (2013). Relationship between the proteasomal system and autophagy. Int. J. Biochem. Mol. Biol. 4, 1-26.
76. Lin, Z., Zhao, D., and Yang, L. (2013). Interaction between misfolded PrP and the ubiquitin-proteasome system in prion-mediated neurodegeneration. Acta Biochim. Biophys. Sin. 45, 477-484. doi: 10.1093/abbs/gmt020
77. Lisak, R. P., Nedelkoska, L., Studzinski, D., Bealmear, B., Xu, W., and Benjamins, J. A. (2011). Cytokines regulate neuronal gene expression: differential effects of Th1, Th2 and monocyte/macrophage cytokines. J. Neuroimmunol. 238, 19-33. doi: 10.1016/j.jneuroim.2011.06.010
78. Lopez Salon, M., Pasquini, L., Besio Moreno, M., Pasquini, J. M., and Soto, E. (2003). Relationship between β-amyloid degradation and the 26S proteasome in neural cells. Exp. Neurol. 180,131-143. doi: 10.1016/S0014-4886(02)00060-2
79. Lowe, J., Blanchard, A., Morrell, K., Lennox, G., Reynolds, L., Billett, M., et al. (1988). Ubiquitin is a common factor in intermediate filament inclusion bodies of diverse type in man, including those of Parkinson's disease, Pick's disease, and Alzheimer's disease, as well as Rosenthal fibres in cerebellar astrocytomas, cytoplasmic bodies in muscle, and mallory bodies in alcoholic liver disease. J. Pathol. 155, 9-15. doi: 10.1002/path.1711550105
80. Majoor-Krakauer, D., Willems, P., and Hofman, A. (2003). Genetic epidemiology of amyotrophic lateral sclerosis. Clin. Genet. 63, 83-101. doi: 10.1046/j.0009-9163.2002.00001.x
81. Mamber, C., Kozareva, D. A., Kamphuis, W., and Hol, E. M. (2013). Shades of gray: the delineation of marker expression within the adult rodent subventricular zone. Prog. Neurobiol. 111, 1-16. doi: 10.1016/j.pneurobio.2013.07.003
82. Mandrekar, S., Jiang, Q., Lee, C. Y., Koenigsknecht-Talboo, J., Holtzman, D. M., and Landreth, G. E. (2009). Microglia mediate the clearance of soluble Abeta through fluid phase macropinocytosis. J. Neurosci. 29, 4252-4262. doi: 10.1523/JNEUROSCI.5572-08.2009
83. Mariani, E., Polidori, M. C., Cherubini, A., and Mecocci, P. (2005). Oxidative stress in brain aging, neurodegenerative and vascular diseases: an overview. J. Chromatogr. 827, 65-75. doi: 10.1016/j.jchromb.2005.04.023
84. McNaught, K. S., Belizaire, R., Isacson, O., Jenner, P., and Olanow, C. W. (2003). Altered proteasomal function in sporadic Parkinson's disease. Exp. Neurol. 179, 38-46. doi: 10.1006/exnr.2002.8050
85. Meissner, F., Molawi, K., and Zychlinsky, A. (2010). Mutant superoxide dismutase 1-induced IL-1C accelerates Als pathogenesis. Proc. Natl. Acad. Sci. U.S.A. 107, 13046-13050. doi: 10.1073/pnas.1002396107
86. Mendonça, D. M. F., Chimelli, L., and Martinez, A. M. B. (2006). Expression of ubiquitin and proteasome in motorneurons and astrocytes of spinal cords from patients with amyotrophic lateral sclerosis. Neurosci. Lett. 404, 315-319. doi: 10.1016/j.neulet.2006.06.009
87. Meyer, K., Ferraiuolo, L., Miranda, C. J., Likhite, S., Mcelroy, S., Renusch, S., et al. (2014). Direct conversion of patient fibroblasts demonstrates non-cell autonomous toxicity of astrocytes to motor neurons in familial and sporadic ALS. Proc. Natl. Acad. Sci. U.S.A. 111, 829-832. doi: 10.1073/pnas.1314085111
88. Middeldorp, J., Kamphuis, W., Sluijs, J. A., Achoui, D., Leenaars, C. H. C., Feenstra, M. G., et al. (2009). Intermediate filament transcription in astrocytes is repressed by proteasome inhibition. FASEB J. 23, 2710-2726. doi: 10.1096/fj.08-127696
89. Miller, Z., Ao, L., Kim, K. B., and Lee, W. (2013). Inhibitors of the immunoprotea-some: current status and future directions. Curr. Pharm. Des. 19, 4140-4151. doi: 10.2174/1381612811319220018
90. Mirza, B., Hadberg, H., Thomsen, P., and Moos, T. (1999). The absence of reactive astrocytosis is indicative ofaunique inflammatoryprocess in Parkinson's disease. Neuroscience 95, 425-432. doi: 10.1016/S0306-4522(99)00455-8
91. Mishto, M., Bellavista, E., Ligorio, C., Textoris-Taube, K., Santoro, A., Giordano, M., et al. (2010). Immunoproteasome LMP2 60HH variant alters MBP epitope generation and reduces the risk to develop multiple sclerosis in Italian female population. PLoS ONE 5:e9287. doi: 10.1371/journal.pone.0009287
92. Mishto, M., Bellavista, E., Santoro, A., Stolzing, A., Ligorio, C., Nacmias, B., et al. (2006). Immunoproteasome and LMP2 polymorphism in aged and Alzheimer's disease brains. Neurobiol. Aging 27, 54-66. doi: 10.1016/j.neurobiolaging.2004.12.004
93. Mizielinska, S., Lashley, T., Norona, F. E., Clayton, E. L., Ridler, C. E., Fratta, P., et al. (2013). C9orf72 frontotemporal lobar degeneration is characterised by frequent neuronal sense and anti sense RNA foci. Acta Neuropathol. 126, 845-857. doi: 10.1007/s00401-013-1200-z
94. Bruniquel, D., and Schwartz, R. H. (2003). Selective, stable demethylation of the interleukin-2 gene enhances transcription byan active process. Nat. Immunol. 4, 235-240.
95. Molofsky, A. V., Krenick, R., Ullian, E., Tsai, H., Deneen, B., Richardson, W. D., et al. (2012). Astrocytes and disease: aneurodevelopmental perspective. GenesDev. 26, 891-907. doi: 10.1101/gad.188326.112
96. Mori, F., Tanji, K., Odagiri, S., Hattori, M., Hoshikawa, Y., Kono, C., et al. (2012).Ubiquitin-related proteins in neuronal and glial intranuclear inclusions in intranuclear inclusion body disease. Pathol. Int. 62, 407-411. doi: 10.1111/j.1440-1827.2012.02812.x
97. Mrak, R. E. (2009). Neuropathology and the neuroinflammation idea. J. Alzheimers Dis. 18,473-481. doi: 10.3233/JAD-2009-1158
98. Mulder, S. D., Nielsen, H. M., Blankenstein, M. A., Eikelenboom, P., and Veerhuis, R. (2014). Apolipoproteins E and J interfere with amyloid-beta uptake by primary human astrocytes and microglia in vitro. Glia 62, 493-503. doi:10.1002/glia.22619
99. Nijholt, D. A., De Graaf, T. R., Van Haastert, E. S., Oliveira, A. O., Berkers, C. R., Zwart, R., et al. (2011). Endoplasmic reticulum stress activates autophagybut not the proteasome in neuronal cells: implications for Alzheimer's disease. Cell Death. Differ. 18, 1071-1081. doi: 10.1038/cdd.2010.176
100. Orre, M., Kamphuis, W., Dooves, S., Kooijman, L., Chan, E. T., Kirk, C. J., et al. (2013).Reactive glia show increased immunoproteasome activity in Alzheimer's disease. Brain 136, 1415-1431. doi: 10.1093/brain/awt083
101. Pappalardo, L. W., Samad, O. A., Black, J. A., and Waxman, S. G. (2014). Voltage-gated sodium channel Na 1.5 contributes to astrogliosis in an in vitro model of glial injury via reverse Na/Ca exchange. Glia 62, 1162-1175. doi: 10.1002/ glia.22671
102. Parpura, V., Heneka, M. T., Montana, V., Oliet, S. H. R., Schousboe, A., Haydon, P. G., et al. (2012). Glial cells in (patho)physiology. J. Neurochem. 121, 4-27. doi: 10.1111/j.1471-4159.2012.07664.x
103. Pasanen, P., Myllykangas, L., Siitonen, M., Raunio, A., Kaakkola, S., Lyytinen, J., et al. (2014). A novel a-synuclein mutation A53E associated with atypical multiple system atrophy and Parkinson's disease-type pathology. Neurobiol. Aging 35, 2180. doi: 10.1016/j.neurobiolaging.2014.03.024
104. Pekny, M., Wilhelmsson, U., and Pekna, M. (2014). The dual role of astrocyte activation and reactive gliosis. Neurosci. Lett. 565, 30. doi: 10.1016/j.neulet.2013.12.071
105. Pelvig, D. P., Pakkenberg, H., Stark, A. K., and Pakkenberg, B. (2008). Neocorti-cal glial cell numbers in human brains. Neurobiol. Aging 29, 1754-1762. doi: 10.1016/j.neurobiolaging.2007.04.013
106. Petrik, M. S., Wilson, J. M., Grant, S. C., Blackband, S. J., Tabata, R. C., Shan, X., et al. (2007). Magnetic resonance microscopy and immunohistochem-istry of the CNS of the mutant Sod murine model of ALS reveals widespread neural deficits. Neuromolecular Med. 9, 216-229. doi: 10.1007/s12017-007-8002-1
107. Pintado, C., Gavilan, M. P., Gavilan, E., Garcia-Cuervo, L., Gutierrez, A., Vitorica, J., et al. (2012). Lipopolysaccharide-induced neuroinflammation leads to the accumulation of ubiquitinated proteins and increases susceptibility to neurodegeneration induced by proteasome inhibition in rat hippocampus. J. Neuroinflammation 9, 87. doi: 10.1186/17422094-9-87
108. Popescu, B. F., Pirko, I., and Lucchinetti, C. F. (2013). Pathology of multiple sclerosis: where do we stand? Continuum (Minneapolis, Minn.) 19, 901-921. doi: 10.1212/01.CON.0000433291.23091.65
109. Pramatarova, A., Laganiere, J., Roussel, J., Brisebois, K., and Rouleau, G. A. (2001). Neuron-specific expression of mutant superoxide dismutase 1 in transgenic mice does not lead to motor impairment. J. Neurosci. 21, 3369-3374.
110. Puttaparthi, K., Van Kaer, L., and Elliott, J. L. (2007). Assessing the role of immuno-proteasomes in a mouse model of familial ALS. Exp. Neurol. 206, 53-58. doi: 10.1016/j.expneurol.2007.03.024
111. Realini, C., Dubiel, W., Pratt, G., Ferrell, K., and Rechsteiner, M. (1994). Molecular cloning and expression of a gamma-interferon-inducible activator of the multicatalytic protease. J. Biol. Chem. 269, 20727-20732.
112. Rechsteiner, M., and Hill, C. P. (2005). Mobilizing the proteolytic machine: cell biological roles of proteasome activators and inhibitors. Trends Cell Biol. 15, 27-33. doi: 10.1016/j.tcb.2004.11.003
113. Reddy, P. H., Williams, M., Charles, V., Garrett, L., Pike-Buchanan, L., Whetsell, W. O., et al. (1998). Behavioural abnormalities and selective neuronal loss in HD transgenic mice expressing mutated full-length HD cDNA. Nat. Genet. 20, 198-202. doi: 10.1038/2510
114. Rock, K. L., Gramm, C., Rothstein, L., Clark, K., Stein, R., Dick, L., et al. (1994). Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 78, 761-771. doi: 10.1016/S0092-8674(94)90462-6
115. Rozemuller, J. M., Eikelenboom, P., and Stam, F. C. (1986). Role of microglia in plaque formation in senile dementia of the Alzheimer type. An immunohisto-chemical study. Virchows Arch. B Cell Pathol. Incl. Mol. Pathol. 51, 247-254. doi: 10.1007/BF02899034
116. Sapp, E., Kegel, K. B., Aronin, N., Hashikawa, T., Uchiyama, Y., Tohyama, K., et al. (2001). Early and progressive accumulation of reactive microglia in the Huntington disease brain. J. Neuropathol. Exp. Neurol. 60, 161-172.
117. Saudou, F., Finkbeiner, S., Devys, D., and Greenberg, M. E. (1998). Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell 95, 55-66. doi: 10.1016/S0092-8674(00)81782-1
118. Schipper-Krom, S., Juenemann, K., Jansen, A. H., Wiemhoefer, A., Van Den Nieuwendijk, R., Smith, D. L., et al. (2014). Dynamic recruitment of active pro-teasomes into polyglutamine initiated inclusion bodies. FEBS Lett. 588, 151-159. doi: 10.1016/j.febslet.2013.11.023
119. Seifert, U., Bialy, L. P., Ebstein, F., Bech-Otschir, D., Voigt, A., Schröter, F., et al. (2010). Immunoproteasomes preserve protein homeostasis upon interferon-induced oxidative stress. Cell142, 613-624. doi: 10.1016/j.cell.2010.07.036
120. Seo, H., Sonntag, K., and Isacson, O. (2004). Generalized brain and skin pro-teasome inhibition in Huntington's disease. Ann. Neurol. 56, 319-328. doi: 10.1002/ana.20207
121. Sharma, R., Fischer, M. T., Bauer, J., Felts, P. A., Smith, K. J., Misu, T., et al. (2010). Inflammation induced by innate immunity in the central nervous system leads to primary astrocyte dysfunction followed by demyelination. Acta Neuropathol. 120, 223-236. doi: 10.1007/s00401-010-0704-z
122. Sheng, J. G., Mrak, R. E., and Griffin, W. S. (1997). Neuritic plaque evolution in Alzheimer's disease is accompanied by transition of activated microglia from primed to enlarged to phagocytic forms. Acta Neuropathol. 94, 1-5. doi: 10.1007/s004010050664
123. Shin, J. Y., Fang, Z. H., Yu, Z. X., Wang, C. E., Li, S. H., and Li, X. J. (2005). Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity. J. Cell Biol. 171,1001-1012. doi: 10.1083/jcb.200508072
124. Shults, C. W. (2006). Lewy bodies. Proc. Natl. Acad. Sci. U.S.A. 103,1661-1668. doi: 10.1073/pnas.0509567103
125. Sijts, E. J., and Kloetzel, P. M. (2011). The role of the proteasome in the generation of MHC class I ligands and immune responses. Cell. Mol. Life Sci. 68,1491-1502. doi: 10.1007/s00018-011-0657-y
126. Simpson, J. E., Ince, P. G., Lace, G., Forster, G., Shaw, P. J., Matthews, F., et al. (2010). Astrocyte phenotype in relation to Alzheimer-type pathology in the ageing brain. Neurobiol. Aging 31, 578-590. doi: 10.1016/j.neurobiolaging.2008. 05.015
127. Smith, D. M., Kafri, G., Cheng, Y., Ng, D., Walz, T., and Goldberg, A. L. (2005). ATP binding to PAN or the 26S ATPases causes association with the 20S proteasome, gate opening, and translocation of unfolded proteins. Mol. Cell. 20, 687-698. doi: 10.1016/j.molcel.2005.10.019
128. Sofroniew, M. V., and Vinters, H. V. (2010). Astrocytes: biologyand pathology. Acta Neuropathol. 119, 7-35. doi: 10.1007/s00401-009-0619-8
129. Solano, R. M., Casarejos, M. J., Menendez-Cuervo, J., Rodriguez-Navarro, J. A., Garcia De Yebenes, J., and Mena, M. A. (2008). Glial dysfunction in Parkin null mice: effects of aging. J. Neurosci. 28, 598-611. doi: 10.1523/JNEUROSCI.4609-07.2008
130. Sosunov, A. A., Guilfoyle, E., Wu, X., Mckhann, G. M. 2nd, and Goldman, J. E. (2013). Phenotypic conversions of "protoplasmic" to "reactive" astrocytes in Alexander disease. J. Neurosci. 33, 7439-7450. doi: 10.1523/JNEUROSCI.4506-12.2013
131. Stefanova, N., Kaufmann, W. A., Humpel, C., Poewe, W., and Wenning, G. K. (2012). Systemic proteasome inhibition triggers neurodegeneration in a transgenic mouse model expressing human alpha-synuclein under oligodendrocyte promoter: implications for multiple system atrophy. Acta Neuropathol. 124, 51-65. doi: 10.1007/s00401-012-0977-5
132. Stohwasser, R., Giesebrecht, J., Kraft, R., Müller, E., Hausler, K. G., Ketten-mann, H., et al. (2000). Biochemical analysis of proteasomes from mouse microglia: induction ofimmunoproteasomes byinterferon-y andlipopolysaccha-ride. Glia 29, 355-365. doi: 10.1002/(SICI)1098-1136(20000215)29:4<355::AID-GLIA6>3.0.CO;2-4
133. Tai, Y. F., Pavese, N., Gerhard, A., Tabrizi, S. J., Barker, R. A., Brooks, D. J., et al. (2007). Microglial activation in presymptomatic Huntington's disease gene carriers. Brain 130, 1759-1766. doi: 10.1093/brain/awm044
134. Tambuyzer, B. R., Ponsaerts, P., and Nouwen, E. J. (2009). Microglia: gatekeepers of central nervous system immunology. J. Leukoc. Biol. 85, 352-370. doi: 10.1189/jlb.0608385
135. Tanaka, Y., Engelender, S., Igarashi, S., Rao, R. K., Wanner, T., Tanzi, R. E., et al. (2001). Inducible expression of mutant alpha-synuclein decreases proteasome activity and increases sensitivity to mitochondria-dependent apoptosis. Hum. Mol. Genet. 10, 919-926. doi: 10.1093/hmg/10.9.919
136. Tang, G., Perng, M. D., Wilk, S., Quinlan, R., and Goldman, J. E. (2010). Oligomers of Mutant Glial Fibrillary Acidic Protein (GFAP) inhibit the protea-some system in Alexander disease astrocytes, and the small heat shock protein aB-crystallin reverses the inhibition. J. Biol. Chem. 285, 10527-10537. doi: 10.1074/jbc.M109.067975
137. Tang, G., Xu, Z., and Goldman, J. E. (2006). Synergistic effects of the Sapk/Jnk and the proteasome pathway on glial fibrillary acidic protein (Gfap) accumulation in Alexander disease. J. Biol. Chem. 281, 38634-38643. doi: 10.1074/jbc.M604942200
138. Tao, J., Wu, H., Lin, Q., Wei, W., Lu, X., Cantle, J. P., et al. (2011). Deletion of astroglial dicer causes non-cell-autonomous neuronal dysfunction and degeneration. J. Neurosci. 31, 8306-8319. doi: 10.1523/JNEUROSCI.0567-11.2011
139. Tashiro, Y., Urushitani, M., Inoue, H., Koike, M., Uchiyama, Y., Komatsu, M., et al. (2012). Motor neuron-specific disruption of proteasomes, but not autophagy, replicates amyotrophic lateral sclerosis. J. Biol. Chem. 287, 42984-42994. doi: 10.1074/jbc.M112.417600
140. Thompson, L. M., Aiken, C. T., Kaltenbach, L. S., Agrawal, N., Illes, K., Khoshnan, A., et al. (2009). Ikk phosphorylates huntingtin and targets it for degradation by the proteasome and lysosome. J. Cell Biol. 187, 1083-1099. doi: 10.1083/jcb.200909067
141. Tofaris, G. K., Razzaq, A., Ghetti, B., Lilley, K. S., and Spillantini, M. G. (2003). Ubiquitination of a-Synuclein in Lewy bodies is a pathological event not associated with impairment of proteasome function. J. Biol. Chem. 278,44405-44411. doi: 10.1074/jbc.M308041200
142. Tong, X., Ao, Y., Faas, G. C., Nwaobi, S. E., Xu, J., Haustein, M. D., et al. (2014). Astrocyte Kir4.1 ion channel deficits contribute to neuronal dysfunction in Huntington's disease model mice. Nat. Neurosci. 17, 694-703. doi: 10.1038/nn.3691
143. Trotti, D., Rolfs, A., Danbolt, N. C., Brown, R. H. Jr., and Hediger, M. A. (1999). Sod1 mutants linked to amyotrophic lateral sclerosis selectively inactivate a glial glutamate transporter. Nat. Neurosci. 2,427-433. doi: 10.1038/8091
144. Truant, R., Atwal, R. S., Desmond, C., Munsie, L., and Tran, T. (2008). Huntington's disease: revisiting the aggregation hypothesis in polyglutamine neurodegenerative diseases. FEBSJ. 275,4252-4262. doi: 10.1111/j.1742-4658.2008.06561.x
145. Tsai, Y. C., Fishman, P. S., Thakor, N. V., and Oyler, G. A. (2003). Parkin facilitates the elimination of expanded polyglutamine proteins and leads to preservation of proteasome function. J. Biol. Chem. 278, 22044-22055. doi: 10.1074/jbc.M212235200
146. Tseng, B. P., Green, K. N., Chan, J. L., Blurton-Jones, M., and Laferla, F. M. (2008). Abeta inhibits the proteasome and enhances amyloid and tau accumulation. Neurobiol.Aging 29,1607-1618. doi: 10.1016/j.neurobiolaging.2007.04.014
147. Tydlacka, S., Wang, C., Wang, X., Li, S., and Li, X. (2008). Differential activities of the ubiquitin-proteasome system in neurons versus Glia may account for the preferential accumulation of misfolded proteins in neurons. J. Neurosci. 28, 13285-13295. doi: 10.1523/JNEUROSCI.4393-08.2008
148. Van Den Berge, S. A., Middeldorp, J., Zhang, C. E., Curtis, M. A., Leonard, B. W., Mastroeni, D., et al. (2010). Longterm quiescent cells in the aged human subventricular neurogenic system specifically express Gfap-delta. Aging Cell 9, 313-326. doi: 10.1111/j.1474-9726.2010.00556.x
149. van Leeuwen, F. W., De Kleijn, D. P. V., Van Den Hurk, H. H., Neubauer, A., Sonnemans, M. A. F., Sluijs, J. A., et al. (1998). Frameshift mutants of C amyloid precursor protein and Ubiquitin-B in Alzheimer's and Down patients. Science 279, 242-247. doi: 10.1126/science.279.5348.242
150. van Tijn, P., De Vrij, F. M. S., Schuurman, K. G., Dantuma, N. P., Fischer, D. F., Van Leeuwen, F. W., et al. (2007). Dose-dependent inhibition of proteasome activity by a mutant ubiquitin associated with neurodegenerative disease. J. Cell Sci. 120, 1615-1623. doi: 10.1242/jcs.03438
151. Vilchez, D., Boyer, L., Morantte, I., Lutz, M., Merkwirth, C., Joyce, D., et al. (2012). Increased proteasome activity in human embryonic stem cells is regulated by Psmd11. Nature 489, 304-308. doi: 10.1038/nature11468
152. Walker, A. K., Daniels, C. M., Goldman, J. E., Trojanowski, J. Q., Lee, V. M., and Messing, A. (2014). Astrocytic Tdp-43 pathology in Alexander disease. J. Neurosci. 34, 6448-6458. doi: 10.1523/JNEUROSCI.0248-14.2014
153. Walker, F. O. (2007). Huntington's disease. Lancet 369,218-228. doi: 10.1016/S0140-6736(07)60111-1
154. Wang, L., Lin, F., Wang, J., Wu, J., Han, R., Zhu, L., et al. (2012). Expression of mutant N-terminal huntingtin fragment (htt552-100Q) in astrocytes suppresses the secretion of Bdnf. Brain Res. 1449, 69-82. doi: 10.1016/j.brainres.2012.01.077
155. Wyss-Coray, T., Loike, J. D., Brionne, T. C., Lu, E., Anankov, R., Yan, F., et al. (2003). Adult mouse astrocytes degrade amyloid-beta in vitro and in situ. Nat. Med. 9, 453-457. doi: 10.1038/nm838
156. Yamamoto, A., Friedlein, A., Imai, Y., Takahashi, R., Kahle, P. J., and Haass, C. (2005). Parkin phosphorylation and modulation of Its E3 ubiq-uitin ligase activity. J. Biol. Chem. 280, 3390-3399. doi: 10.1074/jbc. M407724200
157. Yan, L. J., Xiao, M., Chen, R., and Cai, Z. (2013). Metabolic dysfunction of astrocyte: an initiating factor in beta-amyloid pathology? Aging Neurodegener. 1, 7-14.
158. Zhang, D., Hu, X., Qian, L., O'callaghan, J. P., and Hong, J. S. (2010). Astrogliosis in CNS pathologies: is there a role for microglia? Mol. Neurobiol. 41, 232-241. doi: 10.1007/s12035-010-8098-4
159. Zhang, H., Tan, C. F., Mori, F., Tanji, K., Kakita, A., Takahashi, H., et al. (2008). Tdp-43-immunoreactive neuronal and glial inclusions in the neostriatum in amyotrophic lateral sclerosis with and without dementia. Acta Neuropathol. 115, 115-122. doi: 10.1007/s00401-007-0285-7
160. Zhao, X., and Yang, J. (2010). Amyloid-beta peptide is a substrate of the human 20S proteasome. ACS Chem. Neurosci. 1, 655-660. doi: 10.1021/ cn100067e
161. Zheng, J., Dasgupta, A., and Bizzozero, O. A. (2012). Changes in 20S subunit composition are largely responsible for altered proteasomal activities in experimental autoimmune encephalomyelitis. J. Neurochem. 121, 486-494. doi: 10.1111/j.1471-4159.2012.07699.x